Biotricity to discuss expansion of remote monitoring medical device products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd
REDWOOD CITY, Calif., Sep 21, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that its Chief…
Biotricity unveils “Biokit” with 3 personal medical devices to expand into cardiac disease management
REDWOOD CITY, Calif., Sep 14, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it has…
Biotricity announces closing of exercise of underwriter’s option to purchase additional common stock
REDWOOD CITY, Calif., Sep 13, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that the…
Biotricity to discuss sales expansion, recent financing, and wearable medical device portfolio expansion at H.C. Wainwright Conference
REDWOOD CITY, Calif., Sep 08, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity completes Nasdaq listing
REDWOOD CITY, Calif., Aug 30, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the closing of…
Biotricity prices $15 million underwritten public offering of common stock and listing on the Nasdaq capital market
REDWOOD CITY, Calif., Aug 26, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of…
Biotricity announces proposed underwritten public offering of common stock in connection with expected Nasdaq listing
REDWOOD CITY, Calif., Aug 25, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends…
Biotricity reports 290% revenue growth year over year in record first quarter
REDWOOD CITY, Calif., Aug 16, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial…
Biotricity to report first quarter Fiscal 2022 financial results on August 16, 2021
REDWOOD CITY, Calif., Aug 12, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will…
Biotricity’s 2021 fiscal fourth quarter growth trend continues into fiscal 2022
REDWOOD CITY, Calif., Jul 07, 2021 (ACCESSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced preliminary…
Biotricity reports record quarterly and annual revenue for Fiscal 2021
REDWOOD CITY, Calif., Jun 15, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide unaudited,…
Biotricity to report fourth quarter fiscal 2021 and financial results on June 15, 2021
REDWOOD CITY, Calif., Jun 09, 2021 (ACCESSWIRE) -- Biotricity Inc. (OTCQB:BTCY) Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company,…